LG
Lawrence P. Guiheen (Director) filed 2 Form 4 reports in the past 24 months (0 purchases, 2 sales), most often in ADMA Biologics, Inc. (ADMA). The largest single filing was $419K of ADMA (20,000 sh × $20.96, as filed), executed Jun 9 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$577K
shares × price, as filed
Last traded
Jun 9 2025
Filed Jun 11 2025
Median ADV $38.1M across their filed names
Open performance→Volume by month
Buys $0
Sells $577K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 24 months
Most traded names
ADMARecent filings
ADMASALE
ADMA Biologics, Inc.
View filing →
$419K20,000 sh × $20.96
Exec Jun 9 2025
Filed Jun 11 2025 · 5:30 PM ET ADMASALE ADMA Biologics, Inc. View filing → $158K
7,779 sh × $20.32
Exec May 21 2025
Filed May 23 2025 · 5:30 PM ET